Press release

DECEMBER 19th 2018

CSV LIFE SCIENCE GROUP ANNOUNCES FASINTERNATIONAL E FASLAB SHARES TRANSFER TO FOCUS ON GROUP CORE BUSINESS

CSV Life Science Group, one of the most relevant companies for engineering, validation, GMP compliance and computer system validation, in chemical and pharmaceutical market, has created, in those years, a group of companies and professionals able to provide integrated solutions to the above market segments.
CSV Life Science Group announces Fasinternational e FasLab 100% shares transfer, to focus on its core business.
The Group, continuously growing, first of all is engaged into research, development and sales of containment systems, quite spread in the market and with excellent growth prospects.
Together with commercial and personnel strengthening, the Group is completing strategic partnership and international acquisition, to expand territorially its presence indirectly (shares acquisition) or directly (companies acquisition or start-up), without reducing the effort in Italy.
Least but not last, CSV Group is consolidating CSV Active, as API trader, after the inspection received by AIFA, to obtain the authorization to be an extra EU API importer.

CONTINUITY IN THE CHANGE

To guarantee a tight cooperation and partnership with the Fasinternational and Faslab buyer, CSV Life Science Group has signed cooperation agreement bridging the handover without affecting the market satisfaction.
CSV Life Science Group board of directors thanks all Fasinternational and Faslab employees, with a particular mention to Mrs. Alessandra Ferrari, for their professionality, dedication and cooperation in those years with CSV Life Science Group